» Authors » Thomas Vognbjerg Sydenham

Thomas Vognbjerg Sydenham

Explore the profile of Thomas Vognbjerg Sydenham including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 152
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasmussen M, Moller F, Gunalan V, Baig S, Bennedbaek M, Christiansen L, et al.
Euro Surveill . 2023 Sep; 28(36). PMID: 37676147
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant...
2.
Agergaard C, Porsbo L, Sydenham T, Hansen S, Steinke K, Larsen S, et al.
Euro Surveill . 2023 Mar; 28(9). PMID: 36862098
From October 2022 through January 2023, nine patients with NDM-5/OXA-48-carbapenemase-producing ST79 were detected in Denmark and subsequently one patient in Iceland. There were no nosocomial links between patients, but they...
3.
Fonager J, Bennedbaek M, Bager P, Wohlfahrt J, Ellegaard K, Ingham A, et al.
Euro Surveill . 2022 Mar; 27(10). PMID: 35272746
Following emergence of the SARS-CoV-2 variant Omicron in November 2021, the dominant BA.1 sub-lineage was replaced by the BA.2 sub-lineage in Denmark. We analysed the first 2,623 BA.2 cases from...
4.
Pedersen R, Tornby D, Bang L, Madsen L, Skov M, Sydenham T, et al.
Clin Microbiol Infect . 2021 Nov; 28(2):304.e1-304.e3. PMID: 34763059
Objectives: Assessment of whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been propagated during intestinal passage and infectivity is conserved when shed rectally by hospitalized individuals. Methods: An exploratory...
5.
Justesen U, Acar Z, Sydenham T, Johansson A
Anaerobe . 2018 Mar; 54:236-239. PMID: 29501419
This study evaluated the MBT-ASTRA for antimicrobial susceptibility testing of Bacteroides fragilis with different classes of antibiotics. MALDI-TOF MS peak AUCs from suspensions with B. fragilis with and without an...
6.
Sydenham T, Bek-Thomsen M, Andersen S, Kolmos B, Marmolin E, Trebbien R, et al.
J Clin Virol . 2018 Jan; 99-100:35-37. PMID: 29291537
Background: Diagnosing of influenza rapidly and accurately helps clinicians to initiate appropriate treatment options and isolation protocols. Unnecessary antimicrobial treatment and laboratory testing can also be reduced. Assess commercial alternatives...
7.
Ostergaard A, Sydenham T, Nybo M, Andersen A
BMC Clin Pathol . 2017 Sep; 17:15. PMID: 28855847
Background: Lumbar puncture with quantification of leukocytes and differential count of cellular subsets in the cerebrospinal fluid is a standard procedure in cases of suspected neuroinfectious conditions. However, a number...
8.
Ferlov-Schwensen S, Sydenham T, Hansen K, Hoegh S, Justesen U
Int J Antimicrob Agents . 2017 Jul; 50(4):552-556. PMID: 28666749
Objectives: The purpose of this study was to determine the prevalence of resistance and the cfiA carbapenemase-producing gene in historical Bacteroides fragilis group isolates. Methods: Danish clinical B. fragilis group...
9.
Hansen K, Schwensen S, Henriksen D, Justesen U, Sydenham T
Anaerobe . 2017 Apr; 47:79-85. PMID: 28445776
Members of the Bacteroides fragilis group are opportunistic pathogens and cause severe infections including bacteraemia. As increased levels of antimicrobial resistance in B. fragilis group bacteria can be detected years...
10.
Sydenham T, Hebbelstrup Jensen B, Petersen A, Krogfelt K, Justesen U
Int J Antimicrob Agents . 2017 Apr; 49(5):573-578. PMID: 28366659
The Bacteroides fragilis group constitute a significant portion of the human gut microbiota and comprise a major proportion of anaerobic bacteria isolated in human infections. We established a baseline of...